IS7707A - Efnablöndur með tafða losun sem innihalda lamótrígín - Google Patents

Efnablöndur með tafða losun sem innihalda lamótrígín

Info

Publication number: IS7707A
Authority: IS; Iceland
Prior art keywords: delayed release; preparations containing; release preparations; containing lamotrigine; lamotrigine
Prior art date: 2002-07-29

Application number

IS7707A

Other languages

English (en)

Other versions

IS2681B (is

Inventor

Richard Buxton Ian

Currie Robin

Dela-Cruz Myrna

Wayne Goodson Gary

Karolak Wlodzimierz

Maleki Mehran

Mohan Iyer Vijay

Muppirala Gopal

Frank Parr Alan

Singh Sidhu Jagdev

Allen Stagner Robert

Venkata Vijay-Kumar Akunuri

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-29

Filing date

2005-02-23

Publication date

2005-02-23

2002-07-29 Priority claimed from GB0217493A external-priority patent/GB0217493D0/en

2002-07-29 Priority claimed from GB0217492A external-priority patent/GB0217492D0/en

2003-06-13 Priority claimed from GB0313801A external-priority patent/GB0313801D0/en

2005-02-23 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2005-02-23 Publication of IS7707A publication Critical patent/IS7707A/is

2010-09-15 Publication of IS2681B publication Critical patent/IS2681B/is

Links

230000003111 delayed effect Effects 0.000 title 1
PYZRQGJRPPTADH-UHFFFAOYSA-N lamotrigine Chemical compound NC1=NC(N)=NN=C1C1=CC=CC(Cl)=C1Cl PYZRQGJRPPTADH-UHFFFAOYSA-N 0.000 title 1
229960001848 lamotrigine Drugs 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IS7707A 2002-07-29 2005-02-23 Efnablöndur með tafða losun sem fela í sér lamótrígín IS2681B (is)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0217493A GB0217493D0 (en)	2002-07-29	2002-07-29	Novel methods of treatment
GB0217492A GB0217492D0 (en)	2002-07-29	2002-07-29	Novel method of treatment
GB0313801A GB0313801D0 (en)	2003-06-13	2003-06-13	Novel methods of treatment
PCT/EP2003/008368 WO2004012741A1 (en)	2002-07-29	2003-07-28	Sustained release formulations comprising lamotrigine

Publications (2)

Publication Number	Publication Date
IS7707A true IS7707A (is)	2005-02-23
IS2681B IS2681B (is)	2010-09-15

Family

ID=31499035

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7707A IS2681B (is)	2002-07-29	2005-02-23	Efnablöndur með tafða losun sem fela í sér lamótrígín

Country Status (28)

Country	Link
US (1)	US20050032799A1 (is)
EP (1)	EP1524981B1 (is)
JP (2)	JP4744142B2 (is)
KR (1)	KR100882707B1 (is)
CN (1)	CN100363007C (is)
AR (1)	AR040709A1 (is)
AT (1)	ATE424827T1 (is)
AU (1)	AU2003260336C1 (is)
BR (1)	BRPI0313148B8 (is)
CA (1)	CA2493301A1 (is)
CO (1)	CO5680405A2 (is)
CY (1)	CY1109119T1 (is)
DE (1)	DE60326590D1 (is)
DK (1)	DK1524981T3 (is)
ES (1)	ES2323268T3 (is)
IL (1)	IL166424A (is)
IS (1)	IS2681B (is)
MA (1)	MA27509A1 (is)
MX (1)	MXPA05001243A (is)
MY (1)	MY141049A (is)
NO (1)	NO334221B1 (is)
NZ (1)	NZ537885A (is)
PL (1)	PL213565B1 (is)
PT (1)	PT1524981E (is)
RU (1)	RU2325163C2 (is)
SI (1)	SI1524981T1 (is)
TW (1)	TWI342213B (is)
WO (1)	WO2004012741A1 (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7939102B2 (en) *	2002-06-07	2011-05-10	Torrent Pharmaceuticals Ltd.	Controlled release formulation of lamotrigine
EP1524981B1 (en) *	2002-07-29	2009-03-11	Glaxo Group Limited	Sustained release formulations comprising lamotrigine
EP1686967A4 (en) *	2003-11-25	2012-08-08	Smithkline Beecham Cork Ltd	CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES
WO2006023347A1 (en) *	2004-08-20	2006-03-02	Alpharma, Inc.	Paroxetine formulations
ATE481096T1 (de) *	2005-04-06	2010-10-15	Adamas Pharmaceuticals Inc	Verfahren und zusammensetzungen zur behandlung von zns-erkrankungen
WO2008109343A1 (en) *	2007-03-01	2008-09-12	Memory Pharmaceuticals Corporation	Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith with (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
US20090022789A1 (en) *	2007-07-18	2009-01-22	Supernus Pharmaceuticals, Inc.	Enhanced formulations of lamotrigine
US8486927B2 (en) *	2007-11-09	2013-07-16	Thar Pharmaceuticals	Crystalline forms of lamotrigine
US20090196924A1 (en) *	2008-02-04	2009-08-06	Pramod Kharwade	Controlled-release lamotrigine formulations
US20100323015A1 (en) *	2008-07-18	2010-12-23	Biljana Nadjsombati	Modified release formulation and methods of use
AU2009270768A1 (en) *	2008-07-18	2010-01-21	Valeant Pharmaceuticals International	Modified release formulation and methods of use
US20100323016A1 (en) *	2008-07-18	2010-12-23	Biljana Nadjsombati	Modified release formulation and methods of use
CA2994873A1 (en)	2009-12-02	2011-06-09	Adamas Pharma, Llc	Amantadine compositions and methods of use
WO2011086568A1 (en) *	2010-01-13	2011-07-21	Accutest Research Laboratories (I) Pvt. Ltd	Controlled release composition for lamotrigine
EP2670387A1 (en) *	2011-02-03	2013-12-11	Lupin Limited	Oral controlled release pharmaceutical compositions of bepotastine
WO2014159275A1 (en) *	2013-03-14	2014-10-02	PharmTak, Inc.	Controlled-release pharmaceutical compositions comprising lamotrigine and methods of producing same
CN103920134A (zh) *	2014-05-08	2014-07-16	崔韡	一种治疗儿童眩晕的缓释片及其制备方法
RU2624229C2 (ru) *	2015-12-21	2017-07-03	Общество С Ограниченной Ответственностью "Валента-Интеллект"	Таблетки клозапина с замедленным высвобождением и способ их получения
RU2613192C1 (ru) *	2016-02-18	2017-03-15	Общество С Ограниченной Ответственностью "Валента-Интеллект"	Таблетки клозапина с пролонгированным высвобождением
JP2020506245A (ja) *	2017-02-03	2020-02-27	ジュビラントジェネリックスリミテッドＪｕｂｉｌａｎｔＧｅｎｅｒｉｃｓＬｉｍｉｔｅｄ	ラモトリギン懸濁液剤形
AU2018320946B2 (en)	2017-08-24	2024-05-02	Adamas Pharma, Llc	Amantadine compositions, preparations thereof, and methods of use
SG11202003391XA (en) *	2017-10-27	2020-05-28	Chang Gung Memorial Hospital Linkou	Method for assessing the risk of cutaneous adverse drug reactions induced by anti-epileptic drug lamotrigine, detection reagent thereof and use thereof
US20190247331A1 (en)	2018-02-15	2019-08-15	Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság	Composition and method for treating neurological disease
US10213394B1 (en)	2018-02-15	2019-02-26	Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság	Composition and method for treating neurological disease
US10213393B1 (en)	2018-02-15	2019-02-26	Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság	Composition and method for treating neurological disease
CN112384210A (zh) *	2018-04-25	2021-02-19	纽罗森特里亚股份有限公司	苏糖酸镁组合物及其用途
CN113214177B (zh) *	2021-04-16	2022-05-03	上海奥科达生物医药科技有限公司	一种拉莫三嗪水合物的晶体形式、其制备方法及包含其的组合物
CN116942606A (zh) *	2022-04-18	2023-10-27	上海奥科达医药科技股份有限公司	拉莫三嗪悬浮液和干混悬剂的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4556552A (en) *	1983-09-19	1985-12-03	Colorcon, Inc.	Enteric film-coating compositions
US4704295A (en) *	1983-09-19	1987-11-03	Colorcon, Inc.	Enteric film-coating compositions
JPH0667828B2 (ja) *	1985-10-09	1994-08-31	日研化学株式会社	バルプロ酸ナトリウムの持続性顆粒製剤
US4775536A (en) *	1986-02-24	1988-10-04	Bristol-Myers Company	Enteric coated tablet and process for making
US4816262A (en) *	1986-08-28	1989-03-28	Universite De Montreal	Controlled release tablet
GB8820353D0 (en) *	1988-08-26	1988-09-28	Staniforth J N	Controlled release tablet
IL91398A (en) *	1988-08-30	1994-05-30	Pfizer	Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5827819A (en) *	1990-11-01	1998-10-27	Oregon Health Sciences University	Covalent polar lipid conjugates with neurologically active compounds for targeting
DE69207863T2 (de) *	1991-11-13	1996-06-05	Glaxo Canada	Vorrichtung zur kontrollierten Wirkstoffreigabe
IT1266565B1 (it) *	1993-07-22	1997-01-09	Ct Lab Farm Srl	Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
US5733575A (en) *	1994-10-07	1998-03-31	Bpsi Holdings, Inc.	Enteric film coating compositions, method of coating therewith, and coated forms
AUPN605795A0 (en) *	1995-10-19	1995-11-09	F.H. Faulding & Co. Limited	Analgesic pharmaceutical composition
WO1998007447A1 (en) *	1996-08-23	1998-02-26	Algos Pharmaceutical Corporation	Anticonvulsant containing composition for treating neuropathic pain
GB9625795D0 (en) *	1996-12-12	1997-01-29	Smithkline Beecham Plc	Novel treatment
US6046716A (en) *	1996-12-19	2000-04-04	Colorado Microdisplay, Inc.	Display system having electrode modulation to alter a state of an electro-optic layer
CA2216215A1 (en) *	1997-04-05	1998-10-05	Isa Odidi	Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
GB9726987D0 (en) *	1997-12-22	1998-02-18	Glaxo Group Ltd	Compounds
IL142807A0 (en) *	1998-11-02	2002-03-10	Alza Corp	Controlled delivery of active agents
GB9930079D0 (en) *	1999-12-20	2000-02-09	Glaxo Group Ltd	Medicaments
GB0024517D0 (en) *	2000-10-06	2000-11-22	Glaxo Group Ltd	Use of medicaments
DE10224170A1 (de) *	2002-05-31	2003-12-11	Desitin Arzneimittel Gmbh	Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung
EP1524981B1 (en) *	2002-07-29	2009-03-11	Glaxo Group Limited	Sustained release formulations comprising lamotrigine

2003
- 2003-07-28 EP EP03766343A patent/EP1524981B1/en not_active Expired - Lifetime
- 2003-07-28 CN CNB038223716A patent/CN100363007C/zh not_active Expired - Lifetime
- 2003-07-28 AU AU2003260336A patent/AU2003260336C1/en not_active Expired
- 2003-07-28 AT AT03766343T patent/ATE424827T1/de active
- 2003-07-28 ES ES03766343T patent/ES2323268T3/es not_active Expired - Lifetime
- 2003-07-28 MY MYPI20032831A patent/MY141049A/en unknown
- 2003-07-28 KR KR1020057001633A patent/KR100882707B1/ko not_active Expired - Lifetime
- 2003-07-28 NZ NZ537885A patent/NZ537885A/en not_active IP Right Cessation
- 2003-07-28 SI SI200331585T patent/SI1524981T1/sl unknown
- 2003-07-28 PL PL374982A patent/PL213565B1/pl unknown
- 2003-07-28 CA CA002493301A patent/CA2493301A1/en not_active Withdrawn
- 2003-07-28 MX MXPA05001243A patent/MXPA05001243A/es active IP Right Grant
- 2003-07-28 DE DE60326590T patent/DE60326590D1/de not_active Expired - Lifetime
- 2003-07-28 AR AR20030102702A patent/AR040709A1/es not_active Application Discontinuation
- 2003-07-28 TW TW092120477A patent/TWI342213B/zh not_active IP Right Cessation
- 2003-07-28 BR BRPI0313148A patent/BRPI0313148B8/pt not_active IP Right Cessation
- 2003-07-28 JP JP2004525362A patent/JP4744142B2/ja not_active Expired - Lifetime
- 2003-07-28 WO PCT/EP2003/008368 patent/WO2004012741A1/en not_active Ceased
- 2003-07-28 PT PT03766343T patent/PT1524981E/pt unknown
- 2003-07-28 DK DK03766343T patent/DK1524981T3/da active
- 2003-07-28 RU RU2005105353/14A patent/RU2325163C2/ru active
- 2003-07-29 US US10/629,177 patent/US20050032799A1/en not_active Abandoned
2005
- 2005-01-20 IL IL166424A patent/IL166424A/en unknown
- 2005-01-28 MA MA28074A patent/MA27509A1/fr unknown
- 2005-01-28 CO CO05007005A patent/CO5680405A2/es not_active Application Discontinuation
- 2005-02-22 NO NO20050948A patent/NO334221B1/no not_active IP Right Cessation
- 2005-02-23 IS IS7707A patent/IS2681B/is unknown
2009
- 2009-05-29 CY CY20091100580T patent/CY1109119T1/el unknown
2010
- 2010-10-15 JP JP2010232745A patent/JP2011057683A/ja active Pending

Also Published As

Publication number	Publication date
BR0313148A (pt)	2005-07-12
PL374982A1 (en)	2005-11-14
ES2323268T3 (es)	2009-07-10
BRPI0313148B8 (pt)	2021-05-25
CN1681509A (zh)	2005-10-12
IS2681B (is)	2010-09-15
BRPI0313148B1 (pt)	2019-08-20
IL166424A0 (en)	2006-01-15
NO20050948L (no)	2005-02-22
CO5680405A2 (es)	2006-09-29
EP1524981A1 (en)	2005-04-27
KR20050026054A (ko)	2005-03-14
SI1524981T1 (sl)	2009-08-31
CY1109119T1 (el)	2014-07-02
MY141049A (en)	2010-02-25
RU2325163C2 (ru)	2008-05-27
AU2003260336C1 (en)	2008-05-29
RU2005105353A (ru)	2005-10-27
JP2011057683A (ja)	2011-03-24
AU2003260336A1 (en)	2004-02-23
AR040709A1 (es)	2005-04-13
PT1524981E (pt)	2009-06-17
WO2004012741A1 (en)	2004-02-12
IL166424A (en)	2010-12-30
EP1524981B1 (en)	2009-03-11
JP2005538113A (ja)	2005-12-15
TWI342213B (en)	2011-05-21
DE60326590D1 (de)	2009-04-23
ATE424827T1 (de)	2009-03-15
JP4744142B2 (ja)	2011-08-10
CA2493301A1 (en)	2004-02-12
US20050032799A1 (en)	2005-02-10
PL213565B1 (pl)	2013-03-29
TW200418484A (en)	2004-10-01
MA27509A1 (fr)	2005-09-01
NZ537885A (en)	2007-11-30
MXPA05001243A (es)	2005-06-08
HK1077003A1 (en)	2006-02-03
KR100882707B1 (ko)	2009-02-06
DK1524981T3 (da)	2009-06-22
NO334221B1 (no)	2014-01-13
CN100363007C (zh)	2008-01-23

Publication	Publication Date	Title
IS7707A (is)	2005-02-23	Efnablöndur með tafða losun sem innihalda lamótrígín
ATE418323T1 (de)	2009-01-15	Depot-formulierungen mit verzögerter freisetzung
AU2003241483A8 (en)	2003-11-11	Push release loop
ATE506064T1 (de)	2011-05-15	Analgetika mit verzögerter wirkstoffabgabe
DE60308880D1 (en)	2006-11-16	Embolisation
AU2003219814A1 (en)	2003-09-09	Release agents
AU2003272446A8 (en)	2004-04-08	Connect-release zipping system
AU2003212776A1 (en)	2003-10-08	Microparticles
AU2003220466A1 (en)	2004-04-19	Delayed release dosage forms
GB0204241D0 (en)	2002-04-10	Compound
DE60308622D1 (de)	2006-11-09	Leistungsschalter
GB2388289B (en)	2005-07-06	Bait stop
DE03791054T1 (de)	2005-10-20	Partikel-Trennvorrichtung
FR2840103B1 (fr)	2005-09-23	Disjoncteur
EP1513505A4 (en)	2011-02-16	IMPROVED MODIFIED RELEASE PREPARATION
ZA200500518B (en)	2006-07-26	Sustained release formulations comprising lamotrigine
DE60302376D1 (de)	2005-12-29	Schutzschalter
DE60329987D1 (en)	2009-12-24	Embolisation
DE50213834D1 (de)	2009-10-22	Trennmittel
GB0308941D0 (en)	2003-05-28	Shellfish trap
GB0327727D0 (en)	2003-12-31	Viral microparticles
GB2376164B (en)	2003-07-09	Trap
GB0220046D0 (en)	2002-10-09	Starfish trap
GB0215872D0 (en)	2002-08-14	Microparticles
TW562046U (en)	2003-11-11	Improved traps